Incretin Drugs and Muscle Loss: Why Lean Mass Decline May Not Mean Sarcopenia
A new perspective in Advances in Therapy argues that lean mass loss during incretin therapy reflects physiological body composition remodeling ...
A new perspective in Advances in Therapy argues that lean mass loss during incretin therapy reflects physiological body composition remodeling ...
A new perspective in the International Journal of Obesity argues that obesity, obstructive sleep apnea, and cancer form an interconnected ...
A network meta-analysis of 43 studies and over 930,000 patients finds bariatric surgery reduces major cardiovascular events, heart failure and ...
A formal reply from UC San Diego sleep researchers defends a mechanistic framework for determining how much of obstructive sleep ...
A Brazilian Delphi consensus of twenty specialists concludes that oral, sublingual and intramuscular vitamin B12 all normalise serum levels, yet ...
As powerful new weight-loss drugs transform obesity treatment, leading surgeons argue that metabolic bariatric surgery remains an essential, durable component ...
A new letter in the Journal of Clinical Sleep Medicine argues that obesity-driven obstructive sleep apnea should be formally defined ...
A new review warns that metabolic dysfunction-associated steatotic liver disease in children is independently linked to cardiovascular risk and still ...
New mouse research shows intestinal HIF1α is unnecessary for the metabolic gains of bariatric surgery but plays a vital protective ...
A comprehensive review in Nature Reviews Neurology details how obesity damages the hypothalamus, hippocampus and cerebrovasculature to drive cognitive decline, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine